I am a physician-scientist studying immunity in cancers. T cell-based immunotherapies in the form of checkpoint blockades and cell therapies have revolutionized how we treat cancers. These agents are not uniformly effective for all patients and the durability of these responses are not equal either. The biological processes that determine the responses to immunotherapy are dependent on both T cell intrinsic processes and the tumor microenvironment. Presently, I am studying the role of the tumor microenvironment in shaping anti-tumor T cell immunity.